RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway. (Q38845352)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Zhiyong Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Jie Yuan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Xiyin Wei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ran Tian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ruifang Niu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

English

0 references

publication date

8 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

263-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26253946%20AND%20SRC:MED&resulttype=core&format=json

Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin A2 heterotetramer: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Characterisation and protein expression profiling of annexins in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin A2 is a novel RNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Evaluation of potential Stat3-regulated genes in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Transcriptional regulation of the cyclin D1 gene at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

The role of annexin A2 in tumorigenesis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Prognostic significance of annexin II expression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Cyclin D as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin II represents metastatic potential in clear-cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Examining the role of cyclin D1 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Specific protection against breast cancers by cyclin D1 ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6

Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3529-6